Paya Carlos V — SEC Form 4 filings

SEC reporting owner CIK 1606244. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-16.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-06-10 to 2026-06-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Vaxcyte, Inc. (PCVX)Director410
COLLEGIUM PHARMACEUTICAL, INC (COLL)Director22

Form 4 filings — Paya Carlos V

FiledFormIssuerReported transactionsSource
2026-06-164Vaxcyte, Inc. (PCVX)Grant/award (A): 2,265 @ $0 · Grant/award (A): 11,389 (derivative) @ $0EDGAR
2026-05-184COLLEGIUM PHARMACEUTICAL, INC (COLL)Grant/award (A): 8,741 @ $0EDGAR
2025-06-164Vaxcyte, Inc. (PCVX)Grant/award (A): 3,041 @ $0 · Grant/award (A): 15,372 (derivative) @ $0EDGAR
2025-05-194COLLEGIUM PHARMACEUTICAL, INC (COLL)Grant/award (A): 19,582 @ $0EDGAR
2024-12-104Vaxcyte, Inc. (PCVX)Gift (G): 2,500 @ $0 · Grant/award (A): 2,500 @ $0 · Gift (G): 7,250 (derivative) @ $0 · Grant/award (A): 7,250 (derivative) @ $0EDGAR
2024-06-104Vaxcyte, Inc. (PCVX)Grant/award (A): 1,550 @ $0 · Grant/award (A): 7,250 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1606244 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →